Nektar Therapeutics | NKTR - Ebitda

Aktienkurs
72.22
Täglich Wechseln
-2.62 -3.50%
Monatlich
-1.90%
Jährlich
457.45%
Q1 Prognose
70.05




Ebitda Veränderung Datum
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
ALKERMES USD 100.31M 21.24M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Baxter International USD 426M 36M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 12.55B 6.4B 2025-12
Dr.Reddys Laboratories INR 20.89B 117M 2025-12
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Xencor USD -51.05M 55.28M 2025-12